BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30800311)

  • 1. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
    Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrodermatitis continua of hallopeau successfully treated with adalimumab.
    Sopkovich JA; Anetakis Poulos G; Wong HK
    J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
    Cirone KD; Lovegrove FE
    SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
    Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
    Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast.
    Lanna C; Cesaroni GM; Mazzilli S; Lozzi F; Palumbo V; Diluvio L; Bianchi L; Campione E
    Dermatol Ther; 2019 Jul; 32(4):e12946. PubMed ID: 31025500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
    Iijima S; Okazaki Y; Watanabe S; Maruyama Y
    J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
    Nguyen A; D'Aguanno K; Ridha Z; Tsoukas A; Netchiporouk E
    SAGE Open Med Case Rep; 2023; 11():2050313X231180775. PubMed ID: 37359284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
    García C; Arellano J; Vera V; Corredoira Y
    Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab.
    Lefkir S; Slimani S; Brahimi N; Ladjouze-Rezig A
    Eur J Rheumatol; 2015 Jun; 2(2):78-79. PubMed ID: 27708932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrodermatitis continua of Hallopeau response to optimized biological therapy.
    Adas A; Dadban A; Arnault JP; Chaby G; Lok C
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speckled variance optical coherence tomography for the assessment of nail involvement in acrodermatitis continua of Hallopeau: A case study.
    Conti A; Ciardo S; Mandel VD; Bigi L; Pellacani G
    J Int Med Res; 2016 Sep; 44(1 suppl):119-123. PubMed ID: 27683154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report.
    Alorainy M; Alshaya M; Al-Rikabi A; Ayesh M; Alsaif F
    Case Rep Dermatol; 2017; 9(3):259-264. PubMed ID: 29422844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.
    Shi L; Zeng L; Huang X; Wang B; Zhang Y; Zhang G
    Clin Cosmet Investig Dermatol; 2023; 16():951-957. PubMed ID: 37051587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
    Adışen E; Özer İ; Temel B; Gürer MA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.